Showing results (111-120 of 148) with videos related to
Sort By:
Pageof 15
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 9, 2015
Hormone Use, Reproductive History, and Risk of Lung Cancer: The Women's Health Initiative StudiesAnn G Schwartz, Roberta M Ray, Michele L Cote, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2016
Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of TreatmentCorey J Langer, Coleman Obasaju, Paul Bunn, et al.The Annals of Thoracic Surgery|November 7, 2025
Clinical Characteristics and Surgical Outcomes of Patients Receiving Perioperative Pembrolizumab in KEYNOTE-671Moishe Liberman, David R Jones, Heather Wakelee, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and PlasmaKaren L Reckamp, Vladislava O Melnikova, Chris Karlovich, et al.Cancer Cell|October 22, 2020
Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT ExperienceAnnalisa Trama, Claudia Proto, Jennifer G Whisenant, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 24, 2026
A subgroup analysis of perioperative pembrolizumab in clinical stage II non-small-cell lung cancer from the randomized keynote-671 studyMasahiro Tsuboi, Heather Wakelee, Marina C Garassino, et al.Clinical Chemistry|January 4, 2021
Giant Magnetoresistive Nanosensor Analysis of Circulating Tumor DNA Epidermal Growth Factor Receptor Mutations for Diagnosis and Therapy Response MonitoringJared C Nesvet, Katie A Antilla, Danielle S Pancirer, et al.JAMA Oncology|September 2, 2021
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Randomized Clinical TrialLeora Horn, Ziping Wang, Gang Wu, et al.JTO Clinical and Research Reports|September 30, 2021
Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized StudyJames Chih-Hsin Yang, Karen L Reckamp, Young-Chul Kim, et al.Journal for Immunotherapy of Cancer|July 15, 2025
Napsin A-specific T-cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancerNatalie J Miller, Christina Baik, Joel W Neal, et al.Pageof 15